Financials

News Ideas Technicals

086040 fundamentals

Overview Statements Statistics Dividends Earnings Revenue

An in-depth look to BIOTOXTECH operating, investing, and financing activities

086040 free cash flow for Q4 23 is 1.18 B KRW. For 2023, 086040 free cash flow was -20.69 B KRW and operating cash flow was -16.24 B KRW.

Q2 '22

Q3 '22

Q4 '22

Q1 '23

Q2 '23

Q3 '23

Q4 '23

‪0.00‬

Cash from operating activities

Cash from investing activities

Cash from financing activities

Income statement Balance sheet Cash flow

Currency: KRW

Q2 '22

Q3 '22

Q4 '22

Q1 '23

Q2 '23

Q3 '23

Q4 '23

TTM

YoY growth

—

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

—